Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

RNA interference targeting inhibition of S100A4 suppresses cell growth and promotes apoptosis in human laryngeal carcinoma Hep‑2 cells.

Liu J, Fu S, Xu Y, Zheng Z.

Mol Med Rep. 2014 Sep;10(3):1389-94. doi: 10.3892/mmr.2014.2345. Epub 2014 Jun 19.

PMID:
24969174
2.

Short hairpin RNA-mediated inhibition of S100A4 promotes apoptosis and suppresses proliferation of BGC823 gastric cancer cells in vitro and in vivo.

Hua J, Chen D, Fu H, Zhang R, Shen W, Liu S, Sun K, Sun X.

Cancer Lett. 2010 Jun 1;292(1):41-7. doi: 10.1016/j.canlet.2009.11.007. Epub 2009 Nov 28.

PMID:
19945782
3.

Knockdown of S100A4 chemosensitizes human laryngeal carcinoma cells in vitro through inhibition of Slug.

Liang DP, Huang TQ, Li SJ, Chen ZJ.

Eur Rev Med Pharmacol Sci. 2014 Nov;18(22):3484-90.

4.

Ribonucleic acid interference targeting S100A4 (Mts1) suppresses tumor growth and metastasis of anaplastic thyroid carcinoma in a mouse model.

Shi Y, Zou M, Collison K, Baitei EY, Al-Makhalafi Z, Farid NR, Al-Mohanna FA.

J Clin Endocrinol Metab. 2006 Jun;91(6):2373-9. Epub 2006 Mar 21.

PMID:
16551737
5.

S100A4 silencing suppresses proliferation, angiogenesis and invasion of thyroid cancer cells through downregulation of MMP-9 and VEGF.

Jia W, Gao XJ, Zhang ZD, Yang ZX, Zhang G.

Eur Rev Med Pharmacol Sci. 2013 Jun;17(11):1495-508.

6.

RNA interference suppression of A100A4 reduces the growth and metastatic phenotype of human renal cancer cells via NF-kB-dependent MMP-2 and bcl-2 pathway.

Yang XC, Wang X, Luo L, Dong DH, Yu QC, Wang XS, Zhao K.

Eur Rev Med Pharmacol Sci. 2013 Jun;17(12):1669-80.

7.

Hypomethylation-induced expression of S100A4 increases the invasiveness of laryngeal squamous cell carcinoma.

Liu J, Guo Y, Fu S, Yang M, Sun KL, Fu WN.

Oncol Rep. 2010 Apr;23(4):1101-7.

PMID:
20204297
8.

S100A4 promotes squamous cell laryngeal cancer Hep-2 cell invasion via NF-kB/MMP-9 signal.

Zhang W, Liu Y, Wang CW.

Eur Rev Med Pharmacol Sci. 2014;18(9):1361-7.

9.

Silencing Bmi-1 expression by RNA interference suppresses the growth of laryngeal carcinoma cells.

Yao XB, Wang XX, Liu H, Zhang SQ, Zhu HL.

Int J Mol Med. 2013 May;31(5):1262-72. doi: 10.3892/ijmm.2013.1312. Epub 2013 Mar 20.

PMID:
23525303
10.

Systemic shRNA mediated knock down of S100A4 in colorectal cancer xenografted mice reduces metastasis formation.

Dahlmann M, Sack U, Herrmann P, Lemm M, Fichtner I, Schlag PM, Stein U.

Oncotarget. 2012 Aug;3(8):783-97.

11.

RNA interference targeting against S100A4 suppresses cell growth and motility and induces apoptosis in human pancreatic cancer cells.

Tabata T, Tsukamoto N, Fooladi AA, Yamanaka S, Furukawa T, Ishida M, Sato D, Gu Z, Nagase H, Egawa S, Sunamura M, Horii A.

Biochem Biophys Res Commun. 2009 Dec 18;390(3):475-80. doi: 10.1016/j.bbrc.2009.09.096. Epub 2009 Sep 30.

PMID:
19799859
12.

Downregulation of S100A4 expression by RNA interference suppresses cell growth and invasion in human colorectal cancer cells.

Huang L, Xu Y, Cai G, Guan Z, Cai S.

Oncol Rep. 2012 Apr;27(4):917-22. doi: 10.3892/or.2011.1598. Epub 2011 Dec 20.

13.

S100A4 promotes pancreatic cancer progression through a dual signaling pathway mediated by Src and focal adhesion kinase.

Che P, Yang Y, Han X, Hu M, Sellers JC, Londono-Joshi AI, Cai GQ, Buchsbaum DJ, Christein JD, Tang Q, Chen D, Li Q, Grizzle WE, Lu YY, Ding Q.

Sci Rep. 2015 Feb 13;5:8453. doi: 10.1038/srep08453.

14.

Relaxin enhances S100A4 and promotes growth of human thyroid carcinoma cell xenografts.

Radestock Y, Willing C, Kehlen A, Hoang-Vu C, Hombach-Klonisch S.

Mol Cancer Res. 2010 Apr;8(4):494-506. doi: 10.1158/1541-7786.MCR-09-0307. Epub 2010 Mar 23.

15.

S100A4 interacts with p53 in the nucleus and promotes p53 degradation.

Orre LM, Panizza E, Kaminskyy VO, Vernet E, Gräslund T, Zhivotovsky B, Lehtiö J.

Oncogene. 2013 Dec 5;32(49):5531-40. doi: 10.1038/onc.2013.213. Epub 2013 Jun 10.

PMID:
23752197
16.

[RNA interference targeting c-Met inhibits proliferation of human laryngeal carcinoma Hep-2 cell line in vitro and in its xenografts in nude mice].

Ji CY, Xie ZN, Chen JC, Wang YN, Guan LL, Li HT, Zhang M, Liu RR.

Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2010 Jan;45(1):61-7. Chinese.

PMID:
20398542
17.
18.

shRNA-targeted cyclooxygenase (COX)-2 inhibits proliferation, reduces invasion and enhances chemosensitivity in laryngeal carcinoma cells.

Wang R, Wang X, Lin F, Gao P, Dong K, Zhang HZ.

Mol Cell Biochem. 2008 Oct;317(1-2):179-88. doi: 10.1007/s11010-008-9847-9. Epub 2008 Jul 1.

PMID:
18592138
19.

S100A4 contributes to the suppression of BNIP3 expression, chemoresistance, and inhibition of apoptosis in pancreatic cancer.

Mahon PC, Baril P, Bhakta V, Chelala C, Caulee K, Harada T, Lemoine NR.

Cancer Res. 2007 Jul 15;67(14):6786-95.

20.

Knockdown of S100A4 blocks growth and metastasis of anaplastic thyroid cancer cells in vitro and in vivo.

Zhang K, Yu M, Hao F, Dong A, Chen D.

Cancer Biomark. 2016 Sep 26;17(3):281-291.

PMID:
27802204

Supplemental Content

Support Center